Hastie Graham, Soufi Mazen, Wilson James, Roy Bibhas
Central Manchester University Hospitals NHS Trust, Trafford General Hospital, Moorside Road, Manchester M41 5SL, United Kingdom.
J Orthop. 2018 Jan 31;15(1):239-241. doi: 10.1016/j.jor.2018.01.046. eCollection 2018 Mar.
We aimed to assess the effectiveness of PRP injections in lateral epicondylitis of the elbow as it was felt after PRP introduction the numbers of patients requiring surgery for had reduced.
We conducted a retrospective review of cases from the 1 January 2008 to 31st December 2015. The numbers of patients undergoing surgical release and the numbers of patients requiring PRP injections were recorded each year and the numbers of patients requiring surgery was compared pre and post PRP injection to ascertain if PRP introduction reduced surgical intervention.
Prior to PRP, a yearly mean of 12.75 patients underwent surgery, since PRP this reduced to 4.25 patients, P < 0.001. This leads to an absolute risk reduction of 0.773 and number needed to treat of 1.3. PRP injection successfully reduced symptoms in 56/64 (87.5%) patients in our study.
We consider PRP injection, for intractable lateral epicondylitis of the elbow, not only a safe but also very effective tool in reducing symptoms and have shown it has reduced the need for surgical intervention in this difficult cohort of patients.
我们旨在评估富血小板血浆(PRP)注射治疗肘部外侧上髁炎的有效性,因为在引入PRP后,我们感觉需要进行手术治疗的患者数量有所减少。
我们对2008年1月1日至2015年12月31日期间的病例进行了回顾性研究。记录每年接受手术松解的患者数量和需要接受PRP注射的患者数量,并比较PRP注射前后需要手术的患者数量,以确定引入PRP是否减少了手术干预。
在使用PRP之前,每年平均有12.75例患者接受手术,自使用PRP以来,这一数字降至4.25例,P<0.001。这导致绝对风险降低0.773,治疗所需人数为1.3。在我们的研究中,PRP注射成功减轻了56/64(87.